% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{AbuRumeileh:277429,
author = {Abu-Rumeileh, Samir and Scholle, Leila and Mensch,
Alexander and Großkopf, Henning and Ratti, Antonia and
Kölsch, Anna and Stoltenburg-Didinger, Gisela and Conrad,
Julian and De Gobbi, Anna and Barba, Lorenzo and Steinacker,
Petra and Klafki, Hans-Wolfgang and Oeckl, Patrick and
Halbgebauer, Steffen and Stapf, Caroline and Posa, Andreas
and Kendzierski, Thomas and Silani, Vincenzo and Hausner,
Lucrezia and Ticozzi, Nicola and Froelich, Lutz and
Weishaupt, Jochen Hans and Verde, Federico and Otto, Markus},
title = {{P}hosphorylated tau 181 and 217 are elevated in serum and
muscle of patients with amyotrophic lateral sclerosis.},
journal = {Nature Communications},
volume = {16},
number = {1},
issn = {2041-1723},
address = {[London]},
publisher = {Springer Nature},
reportid = {DZNE-2025-00412},
pages = {2019},
year = {2025},
abstract = {Blood phosphorylated (p)-tau 181 and p-tau 217 have been
proposed as accurate biomarkers of Alzheimer's disease (AD)
pathology. However, blood p-tau 181 is also elevated in
amyotrophic lateral sclerosis (ALS) without a clearly
identified source. We measured serum p-tau 181 and p-tau 217
in a multicentre cohort of ALS (n = 152), AD (n = 111) cases
and disease controls (n = 99) recruited from four different
centres. Further, we investigated the existence of both
p-tau species using immunohistochemistry (IHC) and mass
spectrometry (MS) in muscle biopsies of ALS cases (IHC: n =
13, MS: n = 5) and disease controls (IHC: n = 14, MS: n = 5)
from one cohort. Serum p-tau 181 and p-tau 217 were higher
in AD and ALS patients compared to disease controls. IHC and
MS analyses revealed the presence of p-tau 181 and 217 in
muscle biopsies from both ALS cases and disease controls,
with ALS samples showing increased p-tau reactivity in
atrophic muscle fibres. Blood p-tau species could
potentially be used to diagnose both ALS and AD.},
keywords = {Humans / Amyotrophic Lateral Sclerosis: blood / Amyotrophic
Lateral Sclerosis: metabolism / Amyotrophic Lateral
Sclerosis: pathology / tau Proteins: metabolism / tau
Proteins: blood / Male / Female / Middle Aged / Aged /
Phosphorylation / Biomarkers: blood / Alzheimer Disease:
blood / Alzheimer Disease: metabolism / Alzheimer Disease:
pathology / Alzheimer Disease: diagnosis / Muscle, Skeletal:
metabolism / Muscle, Skeletal: pathology / Case-Control
Studies / Biopsy / Aged, 80 and over / Adult / Cohort
Studies / tau Proteins (NLM Chemicals) / Biomarkers (NLM
Chemicals) / MAPT protein, human (NLM Chemicals)},
cin = {AG Öckl / Clinical Study Center (Ulm)},
ddc = {500},
cid = {I:(DE-2719)5000073 / I:(DE-2719)5000077},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40044663},
pmc = {pmc:PMC11882981},
doi = {10.1038/s41467-025-57144-7},
url = {https://pub.dzne.de/record/277429},
}